The computation of basic net loss per share is based on the weighted-average number of our common shares outstanding during the period. The computation of diluted net loss per share is based on the weighted-average number of our common shares and dilutive potential common shares, which primarily include shares that may be issued under our stock option, RSU, and Employee Stock Purchase Plans ("ESPP") (collectively, "dilutive securities") as determined under the treasury stock method.

The following table sets forth the computation of basic and diluted net loss per share (in millions, except per share data):


	Year Ended December 31,
	2024		2023		2022
Net loss (Numerator):
Net loss	$	(283)	$	(307)	$	(267)
Weighted-average shares (Denominator):




Weighted-average shares for basic and diluted EPS	90.1		74.0		72.0

Net loss per share
Basic and diluted	$	(3.14)	$	(4.15)	$	(3.71)

The following table summarizes potentially dilutive securities excluded from the computation of diluted net loss per share calculations because they would have been antidilutive (in millions):


	At December 31,
	2024	2023	2022
Common stock options issued and outstanding	15.5	13.5	12.0
Restricted stock units issued	2.2	1.5	1.3
Employee Stock Purchase Plan shares	0.3	0.3	0.2
Total potential dilutive securities	18.0	15.3	13.5

We have also excluded the effect of Gilead's right to purchase additional shares of our common stock from the calculation as these rights had no intrinsic value at December 31, 2024, 2023 or 2022.